One Price. All varieties. For Everyone.
Why? Because we can. Because we should.
At Bedrocan we have been growing cannabis for two decades. Over 20,000 patients and governments across seven countries trust our reliability and commitment to integrity. And that commitment can’t stop just with standardized products. Medicine must be affordable.
We are working hard to advocate for universal and tax-free coverage of medicinal cannabis in Canada. But affordability cannot wait. Through years of refining our growing processes, we have established best-in-class production methods that allow us to produce a premium product efficiently. Today we use this experience to make our medical cannabis affordable for Canadian patients.
True Compassionate Pricing covers all of our varieties for all of our clients.
Now affordable for all Canadians. That is True Compassionate Pricing.
The finer points are available below. ↓
Our heritage has its roots in the disciplined agricultural traditions of the northern parts of the Netherlands. In 1984, Bedrocan BV began specializing in the indoor cultivation of plants under standardized and controlled conditions, growing chicory, culinary herbs, potted plants and other crops. Building on this expertise, in the 1990s, we turned our focus to using the most advanced agricultural technology to develop something new: standardized, quality controlled whole-flower cannabis.
Today, Bedrocan is the world’s most experienced producer of legal medical cannabis.
Bedrocan BV has been the trusted supplier of cannabis to the Dutch Ministry of Health for 14 years, and our products have been used with confidence by more than 20,000 patients in Canada and six European countries.
Bedrocan is the only company in the world that has the proven capability of producing standardized whole-flower medical cannabis. Through a combination of stable plant genetics and proprietary, automated, high-tech production techniques, Bedrocan has the capacity to grow varieties that contain consistent levels of cannabinoids and terpenes every time.
So, why should you care? For one, its not just about stable THC and CBD from one lot to another, but rather its about balancing over 100 active components from cannabinoids to terpenes.
Cannabinoids are the active ingredients that deliver the therapeutic effects of cannabis, the most famous of which being tetrahydrocannabinol (THC) and cannabidiol (CBD). Terpenes are the aromatic compounds that give cannabis varieties their distinctive smells and tastes, and there is also research suggesting that terpenes work synergistically with cannabinoids, modifying or enhancing their therapeutic effects in specific ways.
Standardization is the only method of ensuring that health professionals and patients can expect consistent therapeutic effect over time, allowing for accurate dosing, and proper monitoring of the product’s efficacy, safety and side effects. Only standardized products can be used for proper scientific research studies, because results can be compared over time and clear conclusions can be drawn.
Other cannabis producers may achieve a level of standardization in certain products by milling and blending varieties with different cannabinoid levels, but this process only creates equal levels of one or two target compounds (typically THC and/or CBD) – not the entire cannabinoid and terpene profile. Bedrocan can standardize cannabis plants down to the whole-flower level, with consistent cannabinoid and terpene content with the same rigour as traditional prescription medicines.
Bedrocan believes all medicines – cannabis included – should be standardized, and thereby, more reliable.
Every cannabis producer regulated by the Marihuana for Medical Purposes Regulations is held to high standards with regards to cleanliness, testing requirements and strict pesticide and fungicide restrictions. At Bedrocan, we consider these quality assurance measures to be the baseline - a starting point.
Bedrocan Canada’s production facility incorporates the proprietary design, software and standardized production techniques developed through decades of growing experience in the Netherlands and builds on this with next generation technology, a further step beyond what is currently used at our Dutch sites.
Bedrocan’s growing rooms use state of the art environmental control technologies to control every possible variable, including light, temperature, humidity and mineral nutrients. Each of these rooms are sealed with airlock doors to prevent contact with airborne contaminants. Our production process has been specifically refined to grow standardized whole-flower cannabis, without the use of any pesticides, harvesting a fresh crop every week, 52 weeks per year, to a schedule we can predict years in advance.
Introduced in 2003 -
The first strain of cannabis we developed was the Bedrocan variety, named after the company itself. It is a sativa strain featuring 22% THC / < 1% CBD. It is the original “Jack Herer” strain, with original genetics provided by the Dutch Sensi Seed Company, and refined by Bedrocan’s expert breeders.
Introduced in 2014 -
Like Bedrocan, Bedropuur is a high-THC strain at 20% THC / <1% CBD, but as an indica plant, it has distinct effects and terpene profile. This strain, known in the 1990s as “Schwarzenegger”, was originally developed for THC extraction for pharmaceutical development. Bedropuur is available exclusively in Canada.
Introduced in 2007 -
One of the first cannabis varieties ever developed specifically to have a relatively high CBD content, Bediol has a balanced ratio of THC 7% and CBD 9%. Because it is easily tolerated, physicians in the Netherlands often prescribe Bediol for patients who are new to the use of cannabis as a medicine. This strain was bred in-house by Bedrocan, specifically to meet the needs of our patients.
Introduced in 2011 -
We developed Bedica, an indica strain, in response to mounting evidence that there was a real difference in the effects of sativa and indica varieties, with many patients reporting a calming effect from indica varieties. After analyzing large numbers of different varieties in our laboratory, we picked this plant as the most suitable version of an indoor grown Indica. Bedica contains 14% THC / <1% CBD, and was developed from a combination of Afghani and a variety called “Herijuana”.
Introduced in 2014-
Canadian patients were the first in the world to have access to Bedrolite, and the honour of naming this in-house developed strain was given to Bedrocan Canada founder and President Marc Wayne. It is a so-called “CBD-only” variety, with <1% THC / 9% CBD, and the virtual absence of THC means it does not cause psychoactive effects. Bedrolite has become well-known in Canada thanks to media reports regarding its use by a number of patients with severe, intractable (untreatable) forms of epilepsy.
Introduced in 2005 -
Our most recently introduced product in Canada is Bedrobinol, bred in-house by Bedrocan from a combination of Afghani and Pure Haze. Bedrobinol is a sativa variety with a mid-range THC content, containing 14% THC / <1% CBD.
To learn about each of our standardized whole-flower varieties, please visit ourshop
Bedrocan takes the science of cannabis cultivation very seriously, and we have developed unique, proprietary processes that bring unparalleled precision to cannabis production. Each of our standardized varieties is genetically identical to the varieties we developed up to 20 years ago, having originated from one single seed per strain. Patients require access to multiple standardized varieties, with different cannabinoid and terpene profiles, to meet their different and changing needs. Each of our varieties was bred to serve this purpose.
Our plants are not reproduced from new seeds each time. Instead, they are grown by multiplying the original plant material. Bedrocan uses proprietary cloning techniques to give our varieties remarkable genetic stability, and prevent “genetic drift”, a problem resulting from repeated cloning of new mother plants, which can cause changes and weakness in the plant over time.
Finer points: We're confident in our ability to keep all products in stock. A product is in stock if it is available as either Whole Flower or Gran Flos. If a variety is out of stock for more than 12 hours, we offer a 10% discount to clients who have relied on the strain in the previous four months or who have newly registered in the previous 2 months. The 10% discount applies to any other Bedrocan variety and remains in place until the chosen strain is back in stock. At this time the 10% discount does not apply to our cannabis oil products. With True Compassionate Pricing, the price you pay per gram is locked in for the duration of your medical document.
Our cannabis has played an important role in many research projects, in fact Bedrocan cannabis has been used to establish reference standards for major analytical tests used to identify when cannabinoids are present in samples.Learn More